Pfizer Historical Income Statement

PFE -  USA Stock  

USD 51.59  1.50  2.99%

Historical analysis of Pfizer income statement accounts such as Gross Profit of 37.7 B, Net Income of 9.8 B, Net Income Common Stock of 17 B or Net Income to Non Controlling Interests of 37.4 M can show how well Pfizer Inc performed in making a profits. Evaluating Pfizer income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Pfizer's future profits or losses. Financial Statement Analysis is much more than just reviewing and examining Pfizer Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pfizer Inc is a good buy for the upcoming year.
Please check Your Equity Center.
  
Refresh
Share

About Pfizer Income Statement Analysis

Pfizer Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Pfizer shareholders. The income statement also shows Pfizer investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Pfizer Income Statement Chart

Pfizer Inc Income Statement is one of the three primary financial statements used for reporting Pfizer's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Pfizer Inc revenue and expense. Pfizer Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Pfizer Cost of Revenue is projected to decrease significantly based on the last few years of reporting. The past year's Cost of Revenue was at 9.2 Billion. The current year Gross Profit is expected to grow to about 37.7 B, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to about 18.5 B.

Consolidated Income

The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of Net Income to Non Controlling Interests.

Earning Before Interest and Taxes EBIT

Earnings Before Interest and Tax is calculated by adding Income Tax Expense and Interest Expense back to Net Income.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Pfizer Inc financial statement analysis. It represents the amount of money remaining after all of Pfizer Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Revenues

Revenues refers to the total amount of money received by Pfizer for goods sold or services provided during a certain time period. It also includes all of Pfizer Inc sales as well as any other increase in Pfizer Inc equity.Revenues are reported on Pfizer Inc income statement and calculated before any expenses are subtracted. Amount of Revenue recognized from goods sold; services rendered; insurance premiums; or other activities that constitute an earning process. Interest income for financial institutions is reported net of interest expense and provision for credit losses.
Most accounts from Pfizer income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Pfizer Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Your Equity Center.Pfizer Cost of Revenue is projected to decrease significantly based on the last few years of reporting. The past year's Cost of Revenue was at 9.2 Billion. The current year Gross Profit is expected to grow to about 37.7 B, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to about 18.5 B.
 2019 2021 2022 (projected)
Consolidated Income16.3 B18.75 B17.02 B
Direct Expenses10.22 B10 B11.85 B

Pfizer income statement Correlations

Pfizer Account Relationship Matchups

Pfizer income statement Accounts

201720182019202020212022 (projected)
Direct Expenses11.24 B11.25 B10.22 B8.69 B10 B11.85 B
Consolidated Income7.25 B21.36 B11.19 B16.3 B18.75 B17.02 B
Cost of Revenue12.32 B11.23 B11.25 B10.22 B9.2 B9.41 B
Earning Before Interest and Taxes EBIT8.34 B12.26 B11.86 B17.66 B20.31 B18.49 B
Earning Before Interest and Taxes USD8.34 B12.26 B11.86 B17.66 B20.31 B18.49 B
Gross Profit40.5 B41.32 B42.4 B41.53 B37.38 B37.72 B
Net Income21.31 B11.15 B16.27 B9.62 B8.65 B9.78 B
Net Income Common Stock7.21 B21.31 B11.15 B16.27 B18.71 B16.98 B
Net Income Common Stock USD7.21 B21.31 B11.15 B16.27 B18.71 B16.98 B
Net Loss Income from Discontinued Operations(17 M)(2 M)(10 M)(4 M)(4.6 M)(4.96 M)
Net Income to Non Controlling Interests31 M47 M36 M29 M33.35 M37.39 M
Operating Expenses32.15 B29.01 B30.51 B31.93 B28.74 B28.51 B
Operating Income12.84 B11.57 B10.34 B7.7 B8.86 B11.39 B
Revenues52.55 B53.65 B51.75 B41.91 B48.19 B56.78 B
Revenues USD52.82 B52.55 B53.65 B51.75 B46.58 B47.13 B
Research and Development Expense7.89 B7.68 B8.01 B8.65 B7.79 B7.48 B
Selling General and Administrative Expense14.84 B14.8 B14.46 B14.35 B12.91 B13.24 B
Weighted Average Shares5.97 B5.87 B5.57 B5.55 B6.39 B7.14 B
Weighted Average Shares Diluted6.06 B5.98 B5.67 B5.63 B6.48 B7.23 B
Income Tax Expense1.12 B(9.05 B)706 M1.38 B1.25 B1.14 B

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Currently Active Assets on Macroaxis

Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.59
Market Capitalization
281 B
Quarterly Revenue Growth YOY
0.77
Return On Assets
0.12
Return On Equity
0.34
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.